Dated May 10, 2016
http://www.smh.com.au/business/inno...esearch-funding-concerns-20160510-goqjyg.html
Some key points
"Mesoblast conceded Teva had the option of withdrawing its support for the program by mid-year"
"We are looking for non-dilutive funding from parties and we expect to update the market in the short term," Professor Itescu said. During the investor call on Tuesday Professor Itescu pointed in particular to a treatment for lower back pain, on which a deal may occur soon."
"I hope in the short term we will be able to update the market on our strategic position," Professor Itescu said of this program."
Past Article
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |